Mobile Phlebotomy Services Market Report 2026

The mobile phlebotomy services market size has grown rapidly in recent years. It will grow from $1.74 billion in 2025 to $1.94 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to growing elderly population requiring home care, rising demand for routine diagnostic testing, expansion of home healthcare services, increased prevalence of chronic diseases, wider acceptance of mobile healthcare models.

The mobile phlebotomy services market size is expected to see rapid growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing investments in digital health platforms, rising demand for decentralized diagnostic services, expansion of value-based healthcare models, growing adoption of remote patient monitoring, increasing integration with telemedicine ecosystems. Major trends in the forecast period include increasing demand for at-home diagnostic services, rising adoption of remote healthcare solutions, growing preference for patient-centric care models, expansion of corporate and preventive health programs, enhanced focus on convenience-based medical services.

The growing emphasis on preventive healthcare and early diagnosis is expected to drive the expansion of the mobile phlebotomy services market in the coming years. Preventive healthcare and early diagnosis involve the proactive use of routine screenings, clinical assessments, and tests to identify diseases at an early stage and reduce long-term health risks. This emphasis is increasing due to government and health-system investments in national screening and early-detection initiatives that encourage routine testing across populations. Mobile phlebotomy services support these efforts by making blood testing more accessible and convenient, increasing participation in screenings and enabling earlier detection of health conditions. For example, in October 2025, the Australian Institute of Health and Welfare (AIHW), a national public health and statistics agency, reported that over 1.9 million Australians aged 50-74 were screened through Breast Screen Australia during 2023-2024, representing 52% of the target population. Therefore, the rising focus on preventive healthcare and early diagnosis is fueling growth in the mobile phlebotomy services market.

Leading companies in the mobile phlebotomy services market are leveraging digital health innovations to expand care delivery and improve operational efficiency. Technologies such as mobile-enabled phlebotomy scheduling and logistics platforms allow patients to book home specimen-collection visits, track phlebotomist arrival, manage specimen transport, and integrate with laboratory workflows. These systems enable real-time appointment scheduling, route optimization, and continuous specimen-status monitoring. For instance, in November 2023, Quest Diagnostics, a US-based diagnostics company, launched Quest Mobile, a service providing in-home specimen collection across 44 states. The platform features online appointment scheduling, deployment of trained mobile phlebotomists, and direct specimen transport to Quest’s laboratories without third-party handling. Quest Mobile enhances convenience, improves access to laboratory testing, reduces patient travel, and ensures timely, reliable specimen collection.

In February 2025, DocGo, Inc., a US-based provider of technology-enabled mobile health services, acquired PTI Health for an undisclosed amount. Through this acquisition, DocGo gained access to PTI Health’s mobile phlebotomy network, integrations with major national laboratories, and established mid-Atlantic service footprint, thereby strengthening its diagnostic capabilities and expanding service availability. PTI Health is a US-based company specializing in mobile lab collection and phlebotomy services.

Major companies operating in the mobile phlebotomy services market are Quest Diagnostics, NeoGenomics Laboratories Inc., Accu Reference Medical Lab, Sprinter Health, Getlabs, Phlebotek Solutions Corporation, PhlebX, myOnsite Healthcare LLC, Madison Core Labs, VeniExpress Inc., TravaLab LLC, Sunrise Pathology Services, Brio Clinical, Evexia Holdings Inc., Flebo.in, Medifyhome Health Solutions Private Limited, OptiVena, Caresticks Mobile Phlebotomy LLC, Concierge Phlebotomy LLC, Angel On Wheels Mobile Phlebotomy.

North America was the largest region in the mobile phlebotomy services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile phlebotomy services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile phlebotomy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the mobile phlebotomy services market by increasing costs of imported medical consumables, diagnostic kits, portable centrifuges, cold-chain packaging, and personal protective equipment. Service providers in North America and Europe are most affected due to reliance on imported medical supplies, while Asia-Pacific faces cost pressure on equipment sourcing. These tariffs are increasing operational expenses and service pricing. However, they are also encouraging domestic manufacturing of medical consumables, local supplier partnerships, and improved supply chain resilience for mobile healthcare services.

The mobile phlebotomy services market research report is one of a series of new reports that provides mobile phlebotomy services market statistics, including mobile phlebotomy services industry global market size, regional shares, competitors with a mobile phlebotomy services market share, detailed mobile phlebotomy services market segments, market trends and opportunities, and any further data you may need to thrive in the mobile phlebotomy services industry. This mobile phlebotomy services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile phlebotomy services involve the collection of blood by trained phlebotomists at a patient’s home, workplace, or another preferred location. These services include transporting all necessary equipment, safely collecting and labeling specimens, and securely transferring samples to accredited laboratories outside traditional clinical settings.

The main service types of mobile phlebotomy services include routine blood draws, specialty blood draws, pediatric blood draws, geriatric blood draws, and other variants. Routine blood draws are standard laboratory collections performed to evaluate general health, monitor ongoing conditions, or support regular medical checkups. Key applications include diagnostic testing, health screening, therapeutic drug monitoring, and more. End-users include home care settings, assisted living facilities, nursing homes, corporate workplaces, and other locations.

The mobile phlebotomy services market includes revenues earned by entities by providing services such as sample pickup and transport, mobile specimen processing, on-site diagnostic support, patient identification and verification, specimen labelling and documentation, and post-collection coordination with laboratories. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.